Alert B&C Corporation About Us: Overview

Founded: October 1995

Mission: Alert B&C^TM is dedicated to providing high quality technologies, products and solutions to the BioDefence Market in order to improve and maintain the safety and the security of individuals worldwide

Funding: Privately funded from inception until 1999

IPO: November 1999, raised ~$4.5M

Acquisition:

Mass Spectrometry Patent Portfolio from Valorisation-Recherche of University of Montreal: June 2005

Assets, including patent portfolio of Abionix Sarl: May 2006

Strategic Decision:

Enter BioDefense Sector: May 2005

Sale of BioCan Cies: May 2005

Acquisition of Patents: June 2005 and May 2006

ALERT B&C CORPORATION ANNOUNCES ADDITION TO ITS MANAGEMENT TEAM
The Corporation announces the appointment of Mr. David Bokobza to the position of Director Product Development. [More]

ALERT B&C ANNOUNCES AWARDING OF NSERC GRANT FOR THE DEVELOPMENT OF EARLY WARNING AND RESPONSE SYSTEMS
ALERT B&C Corporation (the "Corporation") (TSX Venture Exchange: ACB) is pleased to announce that based on ALERT.S technology the Natural Sciences & Engineering Research Council (NSERC) has awarded a grant in the amount of $1,243,260 to a consortium... [More]

Kurt Soost, Managing Director Of Trimor Capital Corp. announces acquisition of 5,000,500 common shares of ALERT B&C Corporation
[More]

ALERT B&C issued its consolidated financial results
ALERT B&C Corporation (the "Corporation") (TSX Venture Exchange: ACB) issued its consolidated financial results for the three-month period ended December 31, 2007... [More]